Johnson & Johnson Stock (JNJ) Near Record Highs: Halda Deal, Spin‑Off Plans and Talc Risks on November 28, 2025
Updated: November 28, 2025 Johnson & Johnson (JNJ) is closing out 2025 as one of the standout “defensive” winners in the U.S. market. The stock is trading just below a fresh 52‑week high around $205–$208 per share, giving the healthcare giant a market capitalization of roughly $500 billion.FinancialContent Over the last three months, JNJ shares have climbed about 17–18%, handily beating the S&P 500’s roughly 5% gain in the same period. Year‑to‑date, the stock is up about 43%, versus around 16% for the index. Barchart notes that JNJ has been trading above both its 50‑day and 200‑day moving averages since